Healthcare investment firm KICVentures Group, led by orthopaedic spine surgeon Kingsley Chin, has announced the formation of a new company, NANISX, which will focus on less exposure surgery (LES) of the spine in ambulatory surgery centres (ASCs).
NANISX will be divided into two ASC divisions: NANISX Pain, focused on interventional pain management, and NANISX Ortho-Neuro. KICVentures Group has recently merged its holdings in three of its portfolio companies into NANISX: NanoFUSE Biologics, InSpan and Sacrix.
“We are dedicated to support the rise in outpatient spine surgeries by training and equipping interventional pain management doctors, orthopaedic surgeons and neurosurgeons treating degenerative spinal stenosis and sacroiliac joint pain in ASCs for many years,” says Chin.
KICVentures Goup’s co-founder and CEO, Aditya Humad, added: “KICVentures Group sees a different model for the ASC where the doctors are owners, and therefore empowered to make choices to use what is the most innovative and provide effective outcomes at a price that leaves them a profit by streamlining operational overhead.”
